- Home
- FOSL vs HLVX Comparison
FOSL vs HLVX Comparison
Compare FOSL & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- HLVX
- Stock Information
- Founded
- FOSL 1984
- HLVX 2020
- Country
- FOSL United States
- HLVX United States
- Employees
- FOSL N/A
- HLVX N/A
- Industry
- FOSL Consumer Specialties
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- HLVX Health Care
- Exchange
- FOSL Nasdaq
- HLVX Nasdaq
- Market Cap
- FOSL 112.2M
- HLVX 92.6M
- IPO Year
- FOSL 1993
- HLVX 2022
- Fundamental
- Price
- FOSL $1.85
- HLVX $1.86
- Analyst Decision
- FOSL
- HLVX Hold
- Analyst Count
- FOSL 0
- HLVX 5
- Target Price
- FOSL N/A
- HLVX $2.33
- AVG Volume (30 Days)
- FOSL 2.3M
- HLVX 317.3K
- Earning Date
- FOSL 11-07-2024
- HLVX 11-07-2024
- Dividend Yield
- FOSL N/A
- HLVX N/A
- EPS Growth
- FOSL N/A
- HLVX N/A
- EPS
- FOSL N/A
- HLVX N/A
- Revenue
- FOSL $1,223,954,000.00
- HLVX N/A
- Revenue This Year
- FOSL N/A
- HLVX N/A
- Revenue Next Year
- FOSL N/A
- HLVX N/A
- P/E Ratio
- FOSL N/A
- HLVX N/A
- Revenue Growth
- FOSL N/A
- HLVX N/A
- 52 Week Low
- FOSL $0.75
- HLVX $1.55
- 52 Week High
- FOSL $2.61
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- FOSL 55.78
- HLVX 44.78
- Support Level
- FOSL $1.64
- HLVX $1.95
- Resistance Level
- FOSL $2.01
- HLVX $1.97
- Average True Range (ATR)
- FOSL 0.19
- HLVX 0.07
- MACD
- FOSL -0.03
- HLVX -0.02
- Stochastic Oscillator
- FOSL 31.82
- HLVX 10.00
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.